Trials / Recruiting
RecruitingNCT04183660
A Post Market Surveillance Study of the Hemovent Extracorporeal Cardiopulmonary Support System:The MOBYBOX Trial
A Post Market Surveillance Study of the Hemovent Extracorporeal Cardiopulmonary Support System for Cardiac and Respiratory Support: The MOBYBOX Trial
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 60 (estimated)
- Sponsor
- Hemovent GmbH · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate prospectively the safety and performance of the MOBYBOX System in the veno-arterial configuration in patients with cardiorespiratory failure or in the veno-venous configuration in patients with severe respiratory failure.
Conditions
- Cardiac Failure
- Respiratory Failure
- Cardio-Respiratory Failure
- Imminent Cardiorespiratory or Respiratory Failure
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | MOBYBOX System | extracorporeal cardiopulmonary support |
Timeline
- Start date
- 2024-04-30
- Primary completion
- 2026-04-01
- Completion
- 2026-12-01
- First posted
- 2019-12-03
- Last updated
- 2025-05-31
Locations
4 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT04183660. Inclusion in this directory is not an endorsement.